Translate this page into: ARTICLE IN PRESS doi: 10.25259/IJMR_1192_2026 , , 1Department of Clinical Immunology and Rheumatology, Nizams’ Institute of Medical Sciences, Hyderabad, Telangana, India Present address: #NMC Speciality Hospital, Al Nahda, Dubai, UAE * For correspondence: meghnagavali@gmail.com We appreciate the insightful letter-to-editor1 on our study of the efficacy and safety of an adalimumab biosimilar in axial spondyloarthritis (axSpA).2 We acknowledge the concern regarding the...